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Abstract: Dietary phenolic compounds are considered as bioactive compounds that have effects in
different chronic disorders related to oxidative stress, inflammation process, or aging. These compounds,
coming from a wide range of natural sources, have shown a pleiotropic behavior on key proteins that act
as regulators. In this sense, this review aims to compile information on the effect exerted by the phenolic
compounds and their metabolites on the main metabolic pathways involved in energy metabolism,
inflammatory response, aging and their relationship with the biological properties reported in high
prevalence chronic diseases. Numerous in vitro and in vivo studies have demonstrated their pleiotropic
molecular mechanisms of action and these findings raise the possibility that phenolic compounds have
a wide variety of roles in different targets.
Keywords: pleiotropic; phenolic compounds; chronic disorders; metabolites; bioactive compounds;
oxidation; inflammation; aging
1. Introduction
Bioactive compounds are substances present as natural sources that have health benefits beyond
the basic nutritional value of the product. By consensus, bioactive compounds have been defined as
essential and non-essential compounds that are present in nature showing beneficial effects on human
health [1]. Among the great variety of bioactive compounds, phenolic compounds stand out for the
numerous amounts of compounds described with great bioactive potential and structural diversity.
These compounds are secondary metabolites naturally synthesized in plants and present more than
8000 chemical structures [2].
As mentioned, phenolics have a wide physiological activity in humans, such as an antioxidant [3],
antimicrobial [4], anti-allergenic, cardioprotective, antiatherogenic, anti-inflammatory [5–8], and anticancer
activities [9]. Due to this diverse and potential bioactivity, phenolic compounds have become functional
compounds of great interest to the scientific community [10]. However, when phenolic compounds
are ingested, they are usually metabolized suffering various modifications in certain chemical groups
by means of glucuronidation, methylation, or sulfation reactions, among others, which can alter the
biological activity. Besides that, they can be catabolized by the colonic microflora, which may drastically
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affect the absorption of these molecules through the gut barrier [11]. For this reason, it is necessary to
take into account these metabolic reactions as well as their bioactivity when evaluating the bioactivity of
phenolic compounds.
Phenolic compounds have shown a beneficial role against chronic diseases mainly related to
metabolic stress, inflammation, and aging. In the literature, extracts and isolated compounds from
plants have been reported to act on the main metabolic pathways involved in energy metabolism,
inflammatory response, and aging.
In these pathways, there are specific key proteins that act as regulators. The main regulators of
energy metabolism are the AMP-protein kinase (AMPK) [12] and the mammalian target of rapamycin
(mTOR) [13]. In the case of inflammatory response and aging, the nuclear factor-erythroid 2 p45-related
factor 2 (Nrf2) and sirtuins are the main regulatory elements, respectively [14,15]. However, these routes
do not act in isolation, otherwise they are connected to each other. In addition, results obtained by
in vitro and in vivo models support that plant bioactive metabolites exert pleiotropic effects further
than only free radical scavenging capacity [15–19]. They modulate multiple metabolic pathways
through a variety of molecular targets, probably due to its molecular promiscuity and character
diversity acquired through evolution [15].
In this context, the aim of this review is to gather information on the effects exerted by the phenolic
compounds from plant sources and their metabolites in the main metabolic pathways involved in
energy metabolism, inflammatory response, aging, and their relationship with the main chronic
diseases with high prevalence. Specifically, Silybum marianum, Lippia citriodora, Hibiscus sabdariffa,
Theobroma cacao, and Olea europaea have been selected due to the fact that the main families of phenolic
compounds in the diet are fully represented in them.
A literature search of PubMed/MEDLINE using search terms ‘Silybum marianum’ ‘Lippia citriodora’
‘Hibiscus sabdariffa’ ‘Theobroma cacao’ ‘Olea europaea’ AND ‘energy metabolism’ ‘inflammation’ ‘aging’,
alone or in combination, was done up to 11 December 2019. Papers from the last decade were
prioritized, and experimental studies that include the effect of named matrices on named processes
were included both in vitro and in vivo in humans and in animal models.
2. Effect of Bioactive Compounds on Energy Metabolism
Energy metabolism is the processes that involve food intake, transforming the food to release
energy and storing the excess through complex metabolic pathways within the cell. The deregulation
of energy homeostasis has been related to numerous chronic diseases, such as cancer, inflammation,
obesity, diabetes, etc. [20]. In this sense, it has been shown that AMPK, which is a highly conserved
serine/threonine protein kinase formed by a heterotrimer with an α-catalytic subunit, a scaffolding
β-subunit, and a regulatory γ-subunit, presenting each subunit multiple isoforms [12], is an important
regulator of this cellular energy homeostasis [21].
AMPK is activated allosterically in cellular conditions with high concentration of AMP (ischemia,
hypoxia, exercise, metabolic waste, and nutrient starvation) and is inhibited when the ratio ATP:AMP
is high (nutrient-rich conditions) [22]. AMPK is also activated either by phosphorylation of Thr172 in
the AMPKα by liver kinase B1 (LKB1) [23] or by Ca2+/calmodulin-dependent protein kinase β (CaMKK
β) in response to elevated intracellular Ca2+ concentrations, independently of the energetic state of
the cell [24].
AMPK takes part in the regulation of carbohydrate and lipid metabolism, and its activation
resulting in the inhibition of ATP-consuming anabolic pathways, including fatty acid (FA) synthesis,
hepatic gluconeogenesis, cholesterol, and isoprenoid synthesis, and mTOR-mediated protein translation.
AMPK activation also stimulates ATP production through the increase of FA oxidation, muscle glucose
transport, caloric intake and mitochondrial biogenesis [12,21]. In addition to the AMPK, there are other
proteins involved in modulation of insulin effects on lipid metabolism as protein kinase B (Akt/PKB)
and protein kinase C (PKC)-ζ [25].
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Adipogenic transcription factors as PPARγ and C/EBP-α induce gene expression changes
characteristic of mature adipocytes and remain elevated for the life of the cells [26]. These factors
positively regulate each other’s expression since PPARγ can promote adipogenesis in C/EBPα-deficient
cells [27]. Adipogenesis is the process by which undifferentiated precursor cells differentiate into fat
cells and occurs in different stages. First, the growth-arrested preadipocytes initiate mitotic clonal
expansion (MCE), this allows reentry into the cell cycle for another two rounds of division. After the
MCE, the adipocyte differentiation is divided into the early, intermediate, and late stages. In the early
stage, C/EBPβ and C/EBPδ increase, producing changes in the expression of PPARγ and C/EBPα that
increase their levels until the beginning of the late stage when their levels start to lower gradually.
Finally, the late stage is also regulated by PPARγ and C/EBPα which have a synergistic effect [28].
On the other hand, there are several proteins that act in the regulation of the lipogenesis, such as fatty
acid synthase (FAS) and sterol regulatory element-binding proteins (SREBPs). FAS is a multi-enzyme
protein that catalyzes fatty acid synthesis. The expression of this protein is regulated by multiple
transcription factors. For example, SREBPs is one of these transcription factors, which also regulates
the expression of proteins that participate in processes such as synthesis of cholesterol, triacylglycerols,
and phospholipids [29].
It is also known that AMPK can inhibit the de novo synthesis of FAs either by direct phosphorylation
and inhibition of the enzymes acetyl-CoA carboxylase (ACC) [30] and 3-hydroxy-3-methyl-glutaryl
(HMG)-CoA reductase [31] or by the inhibition of the SREBP-1c [29].
Regarding energy stress the AMPK can be activated by phosphorylation, then the mTOR pathway
is negatively regulated by directly phosphorylating the regulatory-associated protein of mammalian
target of rapamycin (raptor) and tuberous sclerosis complex protein-2 [12,13]. In the plasma membrane,
numerous receptors such as G protein-coupled receptor (GPCR); insulin-like growth factor receptor
(IGF-R) and insulin receptor (IR) catch the signal that chemokines and growth factors wield on the
cell that have a positive effect on mTOR through PI3K/Akt, since a serine/threonine protein kinase is
activated by Akt [32]. Moreover, mTOR interacts with certain proteins to form two distinct complexes
named mTOR complex 1 (mTORC1) and 2 (mTORC2). mTORC1 responds to energy, stress, amino
acids, oxygen, and growth factors and is sensitive to rapamycin. It promotes cell growth by inducing
anabolic processes and inhibiting catabolic processes. In the case of mTORC2, it responds to growth
factors and regulates cell survival and metabolism, as well as the cytoskeleton, and this is not sensitive
to rapamycin [33].
In summary, mTOR participates in the regulation of several processes such as protein synthesis
and degradation, cell survival, longevity, and proliferation. Also, mTOR signaling pathway plays
a fundamental part in the regulation of adipose tissue functions such as lipid metabolism, adipogenesis,
and thermogenesis [34]. The deregulation or the chronic activation of mTOR may contribute to the
pathogenesis of chronic diseases, such as obesity, non-alcoholic fatty liver disease, tuberous sclerosis
and Alzheimer’s disease [32]. In this sense, it has been discussed the mechanisms by which polyphenols
can delay the molecular pathogenesis of oxidative stress via inhibition of mTOR-signaling pathways.
Besides the main mentioned pathways, the mammalian sirtuin protein family (comprising SIRT1-SIRT7)
are enzymes with an important role in the control of the metabolic status. Sirtuins are nicotinamide
adenine dinucleotide dependent (NAD) enzymes that regulate the action of target transcription factors
and other enzymes by deacetylation at acyl-lysine residues or ADP-ribosylation that allows the control
of the organismal health-span and life-span [35]. In addition, several studies have shown the benefits of
phenolic compounds in neurodegenerative and metabolic disorders by activating certain sirtuins [36].
Table 1 shows different types of trials related to the effect of the selected plants on the main
metabolic pathways related to energy metabolism.
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Table 1. Main parameters of the tests that show the effect of selected plant on the main metabolic pathways related to energy metabolism.
Assay Model Type Source Effective Dose Parameters References
In vitro
Huh7.5.1 human hepatoma and
Jurkat T cells Silymarin (S. marianum extract) 80 µM for 4, 8 and 24 h AMPK and mTOR pathways [13]
Activated T lymphocytes Silymarin (S. marianum extract) 100 µM for 96 h Cell cycle and PI3K/Akt/mTORsignaling pathway [37]
Hypertrophic adipocytes Verbascoside (isolated from L. citriodoraextract) and L. citriodora extract
400 µg/mL for 48 h of L. citriodora
108 µg/mL for 48 h of Verbascoside
Expression of PPARα, FAS,
and AMPK [38]
3T3-L1 Hypertrophic adipocytes 29 compounds of the L. citriodora extract 200 and 400 µg/mL of the L. citriodorafractions for 48 h AMPK activation [39]
3T3-L1 mature adipocytes
L. citriodora extract Verbascoside,
luteolin-7-diglucuronide and loganic
acid isolated from L. citriodora extract
100, 200 and 400 µg/mL of the whole
extract for 24 h
25, 50 and 100 µg/mL of each isolated
compound for 24 h
AMPK activation [40]
PC12 cells Verbascoside (isolated fromL. citriodora extract) 30 µM for 1, 3, 6, 12, 24 h PI3K/Akt/mTOR signaling pathway [41]
Colorectal cancer cells Verbascoside (isolated fromL. citriodora extract) 100 µM for 72 h PI3K/Akt/mTOR signaling pathway [42]
3T3-L1 preadipocytes H. sabdariffa extract 250, 500, 1000, 2000 and 5000 µg/mLfor 36 h Adipocyte differentiation [26]
3T3-L1 preadipocytes Theobromine (isolated from T. cacao) 50, 100, and 150 µg/mL for 6 days Adipocyte differentiation [28]
Human HepG2 cells Cocoa flavanol epicatechin (isolated fromT. cacao) 10 µM for 24 h Lipid metabolism [25]
Rat Müller cells Cocoa enriched with polyphenols 100 ng/mL, 1 µg/mL and 10 µg/mLfor 24 h Sirtuin pathway [43]
Human HepG2 hepatocytes O. europaea fruit pulp extract 10, 20, 40 and 80 µg/mL for 24 h AMPK and SREBP-1c activation [29]
Primary-cultured rat-hepatocytes Oleuropein, hydroxytyrosol and tyrosol(isolated from O. europaea) 10 µM for 24 h of each phenol Lipid synthesis [44]
Breast cancer cells Secoiridoids from extra virgin olive oil - AMPK and mTOR activation [17]
Vascular adventitial fibroblasts Hydroxytyrosol (isolated fromO. europaea) 200 and 400 µM for 24 h Autophagy [45]
3T3-L1 adipocytes Hydroxytyrosol (isolated fromO. europaea) 1.0 and 10 µM for 72 h
AMPK and genes involved in fatty
acid oxidation activation [46]
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Table 1. Cont.
Assay Model Type Source Effective Dose Parameters References
In vivo
Induced inflammation rats H. sabdariffa extract 10, 20, and 40 mg/kg daily for 5 days Oxidative stress andNF-kB translocation [47,48]
Obese mice H. sabdariffa extract 33 mg of total anthocyanins/kg threetimes a week for 8 weeks PPARγ and C/EBP-α transcription [49]
Obese mice MetA (mixture of L. citriodora andH. sabdariffa extracts)
50 and 100 mg/kg once daily for
8 weeks
Adipogenesis-related genes,
oxidation-related genes,
lipogenesis-related genes
expressions and AMPK activation
[50]
Diabetic rats Theobromine (isolated from T. cacao) 5 mg/kg daily for 12 weeks NAD+/SIRT1 activity [51]
Obese rats Epicatechin (isolated from T. cacao) 1 mg/kg daily for 2 weeks Levels of skeletal muscle andabdominal tissue SIRTs and UCP1 [52]
SAMP8 mice Phenolic compounds of olive oil - SIRT1 expression [53]
In vitro/In vivo
HK2 cells
SIRT3 knockout mice
Silybin (isolated from
S. marianum extract)
50 µM for 24 h (in vitro)
200 mg/kg for 7 days (in vivo) Mitochondrial function [54]
Glioblastoma cells Rats Theobromine (isolated from T. cacao) 10 µM for 72 h (in vitro)0.05% w/w for 40 days (in vivo)
Akt/mTOR pathway
NF-κB pathway [32,55]
SH-SY-5Y neuroblastoma cells
db/db mice
Hydroxytyrosol (isolated from
O. europaea)
10 µM for 24h (in vitro)
10 and 50 mg/kg per day for 8 weeks
(in vivo)
AMPK activation [56]
3T3-L1 Hypertrophic adipocytes
Obese/overweight subjects
Polyphenols derived from L. citriodora
and H. sabdariffa extracts
500 µg/mL for 72h (in vitro)
500 mg/day for 2 months (in vivo) AMPK activation [57]
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2.1. Silybum Marianum
The action of several compounds or the entire extract of S. marianum have been evaluated by
in vitro models in different cell lines such as human liver cells, T lymphocytes and HK2 cells.
Lovelace et al. (2015) studied the role of silymarin in the cellular metabolism of both human
liver and T cells (Huh7.5.1 human hepatoma and Jurkat T cells). Silymarin is a flavonoid extract
that contains silibinin, isosilybin, silydianin, and silychristin, obtained from the plant S. marianum.
This study showed that nontoxic doses of silymarin first induced energy stress responses and then,
the cells respond to these stresses with reparative and adaptive changes instead of dying. Moreover,
silymarin modulates metabolic pathways, like AMPK, resulting in the suppression of mTOR and
inflammatory signaling [13]. This action can be divided into two phases. The first phase consists in the
induction of the stress response when the activation of AMPK signaling. In addition, the induction
of DNA-damage-inducible transcript 4 mRNA and protein expression result in the inhibition of
mTOR signaling translating to endoplasmic reticulum stress induction. The second phase results
in the inhibition of the inflammation because the activation of AMPK signaling inhibits the nuclear
factor-κB (NF-κB) signaling. This fact shows that the AMPK presents a major role in transducing
the signal from silymarin-induced stress to anti-inflammatory effects. The effect of silymarin in
the inflammation has also been explained for the Forkhead box O3 inhibition [58], a key conduit
between cell metabolism, growth, and inflammation, and which is associated with suppression of
many inflammatory genes such as C-X-C motif chemokine 10, whose expression has been associated
with many autoimmune diseases [59].
As mentioned earlier, mTOR has several regulatory routes, for example PI3K/Akt/mTOR signaling
route. Gharagozloo et al. (2012) investigated the effect of silymarin on the cell cycle and the
PI3K/Akt/mTOR signaling pathway of activated T lymphocytes. They showed that silymarin inhibited
cell proliferation through the suppression of the mTOR signaling pathway and also through G1 cell
cycle arrest in human activated T lymphocytes in vitro [37].
The effect of some compounds of S. marianum have also been evaluated in both sirtuin 3 (SIRT3)
knockout mice and diabetic Wistar rats. In this case, silybin, the major pharmacologically active
compound of the S. marianum fruit, has also showed the ability to protect against cisplatin-induced
acute kidney injury and tubular cell apoptosis both in vitro (HK2 cells) and in vivo (SIRT3 knockout
mice) by improving mitochondrial function through the elevation of SIRT3 expression [54]. Besides,
it has also been reported that silymarin extracts have an effect on sirtuin 1 (SIRT1). The administration
of silymarin causes a positive regulation of SIRT1 mRNA expression, and this overexpression is related
to a decrease in lipid concentrations, a higher glycogen content and a negative regulation of the
SREBP-1c gene in the diabetic Wistar rats liver. This is a very important achievement in the field
of diabetes research, since diabetes causes a significant increase in fasting blood sugar and in total
cholesterol and triglycerides in the liver [60].
As well as silymarin induces a stress response and suppresses inflammation, there are other natural
phytochemicals derived from plants with this capacity, for example, curcumin and epigallocatechin
have demonstrated the same effects in AMPK pathways [61,62].
2.2. Lippia Citriodora
There are several studies that prove the effect of L. citriodora extract or some of its compounds on
energy metabolism, for example, this effect has been studied in hypertrophic adipocytes, PC12 cells,
and colorectal cancer cells.
Verbascoside is the most abundant phenylpropanoid glycoside compound in L. citriodora.
This plant is known to possess multiple biological activities including anti-inflammatory, antioxidant,
and anticancer as well as anti-obesity effects with AMPK activation [50]. For example, the incubation
of high glucose-induced hypertrophic adipocytes with extract of L. citriodora or verbascoside produces
a change in mRNA expression and protein levels of PPARα, a major regulator of lipid metabolism,
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FAS, lipogenic-related gene, and the central metabolic sensor AMPK. The result of the incubation is
an increase in PPARα, a decrease in FAS and a significant activation of AMPK [38].
29 compounds from L. citriodora obtained by a HPLC semi-preparative purification method
were tested in 3T3-L1 hypertrophic adipocyte model to prove their influence in the activation of
AMPK. This activation was measured by immunofluorescence microscopy, resulting in that flavonoids,
phenylpropanoids and iridoids, mainly luteolin-7-diglucoronide, verbascoside, and gardeoside,
respectively, were the compounds with greater ability to activate AMPK. It was also observed that
several compounds showed a synergic behavior, which provided a greater capacity of activation
of the AMPK [39]. Similarly, Olivares-Vicente et al. (2019) also observed this synergic effect being
verbascoside, luteolin-7-diglucuronide and loganic acid the compounds with greatest capacity to
activate AMPK in mature adipocytes [39,40]. The mechanism of action by which these compounds
exerted this activating action on AMPK could be explained by their direct actuation as agonists
of AMPK, linking to the AMP binding sites of the gamma subunit and/or the different sites of the
interaction zones between the beta and gamma subunits [40]. Since these results showed the ability of
L. citriodora compounds to activate the AMPK pathway, this mechanism could be considered a strategy
against obesity-related metabolic disorders [39,40].
On the other hand, the effect of verbascoside on mTOR has also been tested showing the ability of
this compound to inactivate PI3K/Akt and activate the PI3K/Akt/mTOR signaling pathway in PC12
cells and colorectal cancer cells. [41,42].
The effect of the extract or isolated compounds of L. citriodora has also been evaluated by different
authors in rabbits and obese/overweight human. In this scenario, verbascoside demonstrated the ability
to activate SIRT1 activity in rabbit’s heart and liver. This SIRT1 can regulate antioxidant genes and
participates in the regulation of certain signaling pathways, such as AMPK activation, associated with
metabolic disorders and obesity. Therefore, the antioxidant effect of verbascoside could be regulated
by increasing SIRT1 activity, leading to treatment of obesity and related metabolic disorders through
AMPK activation [63]. Herranz-López et al. (2019) conducted a trial in 56 obese/overweight subjects for
2 months in which a dietary supplement containing 500 mg of a combination of phenolic extracts from
L. citriodora and H. sabdariffa (LC-HS) was administered. The consumption of this dietary supplement
showed a reduction in symptoms associated with obesity-related diseases. In addition, the LC-HS
extract significantly reduced lipid content and increased AMPK activity in a model of hypertrophied
adipocyte cells. Therefore, the results of this study suggested that this dietary supplement causes
a modulation of fat metabolism in adipose tissue, probably mediated by the activation of AMPK [57].
2.3. Hibiscus Sabdariffa
H. sabdariffa is known for presenting antioxidant, antigenotoxic and biomodulatory effects in
animals exposed to toxic agents. This plant also has diuretic, antimicrobial, and antihypertensive
effects [64]. In this sense, Kim et al. (2007) showed that H. sabdariffa acts as a mitogen-activated protein
kinase (MEK) inhibitor. This inhibition blocks significantly the ability of MEK 1/2 to phosphorylate
extracellular signal-regulated kinase 1/2 (ERK1/2) and the expression of PPARγ and C/EBP-α during
adipocyte differentiation induction [26].
Moreover, there are numerous studies conducted in different animal models in which H. sabdariffa
has demonstrated an effect on energy metabolism. For example, phenolic compounds of H. sabdariffa
inhibited inflammation processes by down-regulating cyclooxygenase-2 (COX-2) and inhibiting the
activation of p38 kinase and c-Jun N-terminal kinase (JNK), postulating a relationship between
H. sabdariffa polyphenols, oxidative stress and suppression of nuclear factor-κB (NF-kB) translocation
in a lipopolysaccharide-induced inflammation rat model [47,48].
Regarding, PPARγ and C/EBP-α, when the gene expression of both transcription factors PPARγ and
SREBP-1c is observed, the last one is regulated by C/EBP-α [65]. In fact, in obese mice, the supplementation
with H. sabdariffa extract reduced the transcription of both factors [49]. However, the inactivation of these
transcription factors occurs with the activation of the AMPK, for example, by the phenolic compounds
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present in H. sabdariffa extracts. So, these results suggested that the effects of H. sabdariffa over adipogenesis
are mediated by SREBP-1c and PPARγ regulation through AMPK activation [49].
On the other hand, AMPK and PPARs also participate in the pathogenesis of both alcoholic liver
and non-alcoholic fatty liver diseases, in which fatty acid oxidation is impaired. It has been checked
that the ameliorating of both diseases can be achieved with the administration of AMPK or PPARα
activators both in vitro and in vivo. Phenolics compounds have also demonstrated their effects by
increasing PPARγmediated adiponectin expression, along with AMPK activation [47].
In addition, synergistic effects of L. citriodora and H. sabdariffa extract, Metabolaid® (MetA),
on the metabolism of obese mice fed a high-fat diet were analyzed by Lee et al. (2018). In this
study, with the administration of MetA, it was observed that body-weight gain, white adipose tissue
(WAT), liver weight, serum, and hepatic lipid profiles and serum glucose levels were reduced [50].
Besides, MetA affected to numerous metabolic pathways more significant than that of with the extracts
alone. For example, MetA reduced significantly the expression of the adipogenesis-related genes,
CEBP/α, PPARγ, and SREBP-1c and their target genes, aP2/FABP4 and FAS, whereas increased the
thermogenesis-related genes as uncoupling protein 1 (UCP1) and uncoupling protein 2 (UCP2) in WAT.
Moreover, this extract increased the activation of AMPK and fatty oxidation-related genes, PPARα and
ACS1, while the lipogenesis-related genes were decreased [50].
2.4. Theobroma Cacao
The action of several phytochemicals of T. cacao has been evaluated in different cell lines such as
3T3-L1 preadipocytes, high-glucose treated HepG2 cells or rat Müller cells.
Theobromine is a methylxanthine from the T. cacao. This compound has shown to suppress the
activation of the Akt/mTOR and NF-κB pathways by in vitro and in vivo models [32,55]. In addition,
theobromine has also shown the ability to inhibit adipocyte differentiation in 3T3-L1 preadipocytes
through down-regulation of PPARγ, C/EBPα, aP2 and leptin. Specifically, this compound exerts its
inhibitory effect at the early stage of adipogenesis through AMPK activation and suppression of the
c-Jun N-terminal kinase (JNK) and ERK signaling pathways in 3T3-L1 adipocytes [28].
Regarding flavonoids, epicatechin, a cocoa flavanol, decreases total lipid included in high
glucose-exposed hepatic cells via Akt, AMPK, and PKCζ [25]. This compound also reduces the levels
of SREBP1-c and FAS and increases the levels of PPARα in high-glucose treated HepG2 cells through
the inhibition of PKCζ [26].
Duarte et al. (2015) evaluated the possible protective effects of cocoa on the diabetic retina. In this
study, rat Müller cells were treated with cocoa extract enriched in polyphenols. It was observed that the
activation of PARP-1 and the decrease of the levels of NAD+ and SIRT1 in diabetes were dose-dependent
with oral administration of polyphenolic cocoa extract. This study showed that the cocoa extract
improved the SIRT1 retinal pathway, allowing the protection of the retina in diabetic patients [43].
The effect of some compounds of T. cacao have also been evaluated in different animal models such
as hypertensive rats with induced diabetes and obesity rat model induced by a high-fat diet. In this
regard, Papadimitriou et al. (2014) evaluated the effect of theobromine treatment in spontaneously
hypertensive rats with induced diabetes. They observed that in diabetes mellitus, SIRT1 activity was
reduced by PARP-1 activation and NAD+ depletion due to low concentration of AMPK increasing
NOX4 expression. This is associated with extracellular matrix (ECM) accumulation in the diabetic
kidney. Therefore, an increase in the activation of SIRT1 can be achieved by theobromine administration,
revealing its therapeutic potential for diabetic nephropathy [51].
Gutiérrez-Salmeán et al. (2014) conducted a study in which epicatechin was administered to
obesity rats induced by a high-fat diet. A decrease in the rate of weight gain, blood glucose,
and hypertriglyceridemia were detected. In addition, it was observed that epicatechin restored the
levels of SIRTs and UCP1 in the skeletal muscle and abdominal tissue of obesity-induce rats [52].
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2.5. Olea Europaea
Several studies have demonstrated that the fruit and leaf extracts of O. europaea possess
antihypertensive, antithrombotic, anticancer, antiatherogenic hypoglycemic, anti-inflammatory and
antimicrobial properties [29]. These biological activities have been evaluated in different cell models
to assess the effects on energy metabolism in human HepG2 hepatocytes, rat liver cells, adventitious
vascular fibroblasts, breast cancer cells, SH-SY5Y neuroblastoma cells and 3T3-L1 adipocytes. On this
scenario, O. europaea fruit pulp extract promotes AMPK phosphorylation in human HepG2 hepatocytes.
This phosphorylation causes an activation of AMPK which leads to the inhibition of lipid accumulation
due to the activation of low regulation of FAS expression through SREBP-1c inactivation [29].
Concerning main phenolic compounds of extra virgin olive oil, oleuropein, hydroxytyrosol,
and tyrosol have been reported to their biochemical and pharmacological properties. The effect of these
compounds on the synthesis of lipids in primary cultured rat liver cells has been studied. The results
showed the inhibition of the synthesis of de novo cholesterol and fatty acids without an effect on the cell
viability. In order to clarify the lipid-lowering mechanism of these compounds, the key enzymes in
these processes were evaluated, obtaining as a result the reduction of ACC and HMG-CoA reductase
activities after 2 h of 25 µM phenol treatment. It was also concluded that the ACC inhibition appears
to be mediated by phosphorylation of AMPK [44].
In addition, some secoiridoids from extra virgin olive oil have been reported to activate AMPK,
which results in the inhibition of mTOR in breast cancer cells [17]. This inhibition may be important
in the action against chronic diseases because in these pathologies there are an overactivation of the
nutrient-sensing mTOR due to the loss of responsiveness to active AMPK, a suppressor of mTOR [21].
Hydroxytyrosol has shown a positive regulatory effect on AMPK allowing the prevention of
type 2 diabetes brain damage [66]. Wang et al. (2018) studied the hydroxytyrosol effect in autophagy
in adventitious vascular fibroblasts, observing that it regulated the expression of the SIRT1 mRNA
and protein and that it finally caused the suppression of Akt/mTOR. The authors concluded that
hydroxytyrosol regulated the autophagy of adventitious vascular fibroblasts through the suppression
of Akt/mTOR mediated by SIRT [45]. Following this positive regulatory effect of hydroxytyrosol on
AMPK, other studies have determined in high glucose-induced neuroblastoma SH-SY5Y cell damage
an increase of neuroprotection in db/db mice, which showed hyperglycemia and obesity [56]. Moreover,
in 3T3-L1 adipocytes, this compound is able to act positively in AMPK and on genes involved in fatty
acid oxidation such as PPARα, Cpt1, and PPARγ [46].
Regarding in vivo studies, the effect of O. europaea have been evaluated in model 8 prone to
senescence accelerated mice (SAMP8) and db/db mice. In this sense, it has been observed that the
high intake of phenolic compounds of olive oil, i.e., a high consumption of hydroxytyrosol, positively
increased SIRT1 in SAMP8 mice. This positive effect on SIRT1 led to the stimulation of an antioxidant
response and a decrease in oxidative stress in the heart of SAMP8 mice [53].
3. Effect of Bioactive Compounds on Inflammation Process
Inflammation is a process that is part of the normal repair process when there is damage to
the individual and is essential for protection against bacterial and viral infections and harmful
environmental agents. When the inflammation persists over time, it becomes chronic inflammation
which has been related to several age-related chronic diseases such as Alzheimer’s disease,
atherosclerosis, diabetes, cancer, rheumatoid arthritis, among others [67].
Numerous studies have shown that Nrf2 contributes to the anti-inflammatory process by
organizing the arrest of inflammatory cells and regulating gene expression through the antioxidant
response element (ARE). This signaling pathway allows the regulation of the expression of
anti-inflammatory genes and inhibits the progression of inflammation [14]. Nrf2 is a transcription
factor that plays an important role in the control of the response to oxidative stress.
Under basal conditions, Nrf2 is locked by kelch-like ECH-associated protein (Keap1) by its
two motifs (ETGE and DLG) leading to CUL3-mediated ubiquitination and finally its proteasome
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degradation. While under oxidative stress conditions, Nrf2 dissociates from Keap1, thus Nrf2
accumulates in the nucleus and activates the ARE-gene battery [68]. One of this ARE-gene is HO-1,
upregulated HO-1 transform the heme into CO, bilirubin and free iron. This CO produced acts as
an inhibitor of the NF-kB pathway which decreases the expression of pro-inflammatory cytokines as
interleukin-6 (IL-6) and tumor necrosis factor α (TNF-α), while bilirubin also acts as an antioxidant.
Besides, HO-1 inhibits the activation of pro- and anti-inflammatory cytokines as IL-10 [14].
Although Keap1 is the major regulator Nrf2 activation, Nrf2 can be also activated by additional
signal transduction pathways, e.g., JNK, p38 MAPK, AMPK or PI3K/Akt, promoting anti-oxidative
effects [68]. Both genetic and pharmacological studies propose the existence of a functional cross-talk
between Nrf2 and NF-κB pathways. Nrf2 and NF-κB are key pathways involved in controlling the
balance of cellular redox status and responses to inflammation and stress [69]. When a situation of
oxidative stress occurs, IkB kinase (IKKβ) is activated raising the release and nuclear translocation
of NF-κB. At the nuclear site, NF-κB causes the transcription of pro-inflammatory mediators such as
IL-1, IL-6, TNF-α, inducible nitric oxide synthase (iNOS) and intracellular adhesion cyclooxygenase-2
(COX-2) [14]. Excessive increase in IL-1, IL-6 and TNF-α occurs frequently in an acute inflammatory
response and in several chronic inflammatory diseases [70].
The activity of NF-κB influences Keapl/Nrf2/ARE signaling pathway in different ways. One of
these is Keap1, which degrades IKKβ by ubiquitination, resulting in the inhibition of NF-kB activity.
Furthermore, inflammatory mediators like COX-2 are produced in the inflammatory processes reacting
with Keap1 and activating Nrf2, thereby initiating gene transcription with simultaneous inhibition of
NF-κB activity [14].
Numerous in vivo studies have demonstrated that Nrf2 plays an important effect in several inflammatory
diseases such as gastritis, arthritis or neurodegenerative disease. In this sense, Ahmed et al. (2017) demonstrated
that the absence of Nrf2 reflected greater symptoms of inflammation [14]. Table 2 shows the effects of the
selected matrices on the main metabolic pathways related to inflammation process.
3.1. Silybum Marianum
Isosilybin, a compound present in S. marianum extract presents pharmacological activities which
have been reported on in vitro studies. For example, Zhou et al. (2016) reported that isosilybin
could alleviate the Aβ 25-35-induced oxidative stress damage, which is considered a direct cause
of Alzheimer’s disease, in HT-22 hippocampal cells. They determined the mechanism of action of
isosilybin that significantly increased the protein and mRNA expression of antioxidases, such as
HO-1, glutathione S-transferase (GST), and aldo-keto reductases 1C1 and 1C2 (AKR1C2), through the
activation of NRF2/ARE signaling. This activation induces inhibition of ROS accumulation and
ultimately alleviating Aβ 25-35-induced oxidative stress damage in HT-22 cells [71].
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Table 2. Main parameters of the tests that show the effects of different plant species on the main metabolic pathways related to inflammation.
Assay Model Type Source Effective Dose Parameters References
In vitro
HT-22 hippocampal cells Isosilybin (isolated from S. marianum extract) 10 µM for 18 h Activation of NRF2/ARE signaling [71]
3T3-L1 hypertrophic adipocytes L. citriodora extract 400 µg/mL for 48 h NF-κB expression [38]
LPS-stimulated macrophage RAW 264.7 cells Essential oil from H. sabdariffa 50, 100 and 200 µg/mL for 24 h NF-κB and MAPK signalingpathways activation [70]
Lymph node carcinoma of the prostate cells H. sabdariffa leaf extracts 0.5 mg/mL for 24 h Akt/NF-κB/MMP-9pathway regulation [72]
wild-type and Nrf2 KO astrocytes (−)-epicatechin (isolated from T. cacao) 100 µM for 1 h Nrf2 regulation [73]
LPS-stimulated peritoneal murine macrophages Extra virgin olive oil polyphenolic extract 25 and 50 mg/mL for 18 h AMPK phosphorylation and NF-κBnuclear translocation [74]
Primary astrocytes Maslinic acid (isolated from O. europaea) 1 and 10 µM for 24 h NF-κB nuclear translocation [75]
CD31+/VEGFR-2+ cells Oleacein and oleuropein (isolated from O. europaea) 1, 2, 5 and 10 µM for 3 h HO-1 and Nrf2 levels [76]
In vivo
Rats with arsenic treatment Silybin (isolated from S. marianum extract) 75 mg/kg per day for 4 weeks Nrf2 and NF-κB expressions [77]
NASH mice Silybin (isolated from S. marianum extract) 105 mg/kg per day for 8 weeks NF-κB nuclear translocation [78]
Induced gastric injury rats Silymarin (S. marianum extract) 50 mg/kg for 5 days Nrf2 and NF-κB expressions andpro-inflammatory cytokines levels [79]
Zebrafish Verbascoside (isolated from L. citriodora extract) 400 µg/mL per day for 4 days Nrf2/ARE signalingpathway activation [80]
Rats with induced hepatotoxicity H. sabdariffa extract 100 mg/kg/per day for 4 weeks NF-κB expression and levels ofinflammatory mediators [64]
TPA-induced mouse skin Cocoa polyphenols 40 and 200 mg/kg in a dose MAPKs and NF-kB signalingpathways activation [81]
Rats with induced colon carcinogenesis Cocoa polyphenols Cocoa-rich diet for 8 weeks MAPKs and NF-kB signalingpathways activation [82]
Obese rats Cocoa proteins 150 mg/kg per day for 8 weeks TNF-α protein and mRNA levels [83]
Mice with associated colitis Cocoa 5 and 10% cocoa in the diet for 2 months Nrf2 levels and COX-2 expression [84]
Autoimmune myocarditis rats Oleuropein (isolated from O. europaea) 20 mg/kg per day for 4 weeks MAPKs and NF-κBpathways regulation [85]
Rats with induced renal injury O. europaea leaf extract 100 and 200 mg/kg for 15 days NF-κB nuclear translocation andNrf2, HO-1 and NQO-1 expressions [86]
Rats with induced testicular damage O. europaea leaf extract 300 mg/kg daily for 5 days NF-κB nuclear translocation andNrf2, HO-1 and NQO-1 expressions [87]
In vitro/In vivo
PC12 cells Sprague–Dawley rats Verbascoside (isolated from L. citriodora extract)
10, 30 and 10 µM for 12 h (in vitro)
25 mg/kg in three doses at 3, 6 and 12 h
(in vivo)
HO-1 expression [41]
RAW264.7 macrophage cells/Mice Dp3-Sam (isolated from H. sabdariffa) 50-200 mM for 30 min (in vitro)15 mM/kg for 4 days (in vivo)
MAPK and NF-κB pathways
regulation and levels of
inflammatory mediators
[88]
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Furthermore, the anti-inflammatory effects of certain compounds present in S. marianum have
been evaluated by in vivo studies. In this sense, silybin has shown a potential anti-inflammatory
effect in rats exposed to an arsenic treatment, an environmental and an industrial pollutant [77].
Milton Prabu and Muthumani (2012) observed that the silybin diet supplementation with arsenic
treatment causes the expression of Nrf2 mRNA in the kidney tissue of rats to reverse at the level of the
control group. In addition, the administration of this compound to the rats without arsenic treatment
increases mRNA even above the group control. In this study, the administration of arsenic caused
an over-expression of NF-κB in the kidney tissue that could be reduced to baseline levels with the
administration of silybin [77].
The administration of silybin in a nonalcoholic steatohepatitis (NASH) mouse model showed that
this compound decreased significantly the elevation of p-IKKα/β which is produced by the NASH in
liver [78], allowing the blocking of NF-κB.
Other studies revealed that silymarin up-regulated gastric tissue Nrf2 expression, down-regulated
gastric tissue NF-κB p65 protein expression, that is necessary to activate the NF-κB [89], and decreased
gastric tissue levels of pro-inflammatory cytokines like TNF-α and IL-6 in rats with indomethacin-induced
gastric injury [79].
In general, most of the experimental studies suggest that dietary S. marianum/silybin activates
antioxidant pathways such as Nrf2/HO-1 and downregulates NFκB.
3.2. Lippia Citriodora
L. citriodora extract has demonstrated the ability to downregulate NF-κB expression in 3T3-L1
hypertrophic adipocytes. In this cell line, the gene expression of some cytokines was measured
observing that the plant extract significantly reduced the expression levels of IL-1β,IL-6, TNF-α
and CCL2/MCP-1 [38].
Verbascoside has been shown to have an anti-inflammatory effect in in vivo studies using zebrafish
or Sprague–Dawley rats. Verbascoside stands out for its anti-inflammatory power, since it exerts
a regulation on the Keapl/Nrf2/ARE signaling pathway [41,80,90]. In addition, this phenylpropanoid
has been considered an activator of Nrf2 and an inducer of HO-1 expression in both in vitro (PC12
cells) and in vivo (Sprague–Dawley rats) assays through activation of the ERK and PI3K/Akt signal
pathways [41]. In another study, the protective capacity of verbascoside in the treatment of Parkinson’s
disease was evaluated in a zebrafish model. It was observed that this compound penetrated the blood
brain barrier showing a potential therapeutic value in the treatment of Parkinson’s disease since it
prevents movement disorders and activates the Nrf2/ARE signaling pathway to attenuate oxidative
stress and inflammation [80].
3.3. Hibiscus Sabdariffa
The anti-inflammatory effect of H. sabdariffa extract has been evaluated in different cell lines, such as
macrophages, lymph node carcinoma of prostate cells and macrophage cells RAW264.7; while there
are in vivo studies that have evaluated the effect of this matrix in mice and rats with hepatotoxicity.
The anti-inflammatory activity of the essential oil extracted from H. sabdariffa was evaluated in
LPS-stimulated macrophage RAW 264.7 cells showing an inhibition of the activation of NF-κB and
MAPK (JNK and ERK1/2) signaling pathways that resulted in a decrease of NO and pro-inflammatory
cytokine (IL-1, IL-6, TNF-α, COX-2, and iNOS) production [70].
Chiu et al. (2015) evaluated the action of H. sabdariffa leaf extracts in lymph node carcinoma
of the prostate cells resulting in an inhibitory effect on the activity and expressions of matrix
metalloproteinase-9 (MMP-9). The MMP-9 inhibition is a consequence of NF-κB inactivation by
the H. sabdariffa leaf extracts mediated by Akt [72].
Anthocyanins are the major phenolic compounds in H. sabdariffa, suggesting that the anti-inflammatory
capacity of this plant is caused by these compounds. For example, delphinidin 3-sambubioside (Dp3-Sam)
showed an anti-inflammatory effect by in vivo and in vitro models. The administration of Dp3-Sam in mice
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inhibited the production of inflammatory factors, such as IL-6 and TNF-α, through the downregulation of
cellular signaling including MAPK and NF-κB pathways. On the other hand, the levels of inflammatory
mediators, such as iNOS, NO, IL-6, MCP-1, and TNF- α induced by lipopolysaccharide in RAW264.7
macrophage cells, decreased after the administration of Dp3-Sam [88].
Moreover, H. sabdariffa extract has shown in rats with thioacetamide (TAA)-induced hepatotoxicity
the capacity to inhibit the expression of NF-κB and to decrease the levels of TNF-α, IL-6 and IFN-γ,
which would indicate a hepatoprotective effect [64].
3.4. Theobroma Cacao
The anti-inflammatory effect of the compounds of T. cacao have been evaluated in vitro in primary
astrocytes isolated from wild-type and Nrf2 KO mice and in vivo studies.
Several studies support the idea of the anti-inflammatory capacity of cocoa phenolics. For instance,
the mechanism of action of (−)-epicatechin in this pathway was evaluated in primary astrocytes isolated
from wild-type and Nrf2 KO mice. In addition, the results revealed that this compound protected
astrocytes against hemoglobin toxicity through the positive regulation of Nrf2 and the inhibition of
the activity of activator protein 1 (AP-1). Both cases were mediated by the suppressive action of the
compound in the phosphorylation of JNK and by the nuclear expression of JNK, c-jun, and c-fos.
Besides that, the inhibitory action of (−)-epicatechin on AP-1 activity was independent of Nrf2, since it
occurred in both wild-type and Nrf2 KO astrocytes. Moreover, the positive action of (−)-epicatechin
in Nrf2 did not alter the expression of HO-1, which could be the result of a balance between the
signaling pathways of Nrf2 activation and AP-1 inhibition [73]. On this scenario, Lan et al. (2017)
reported the effect of (−)-epicatechin on the reduction of hemorrhagic stroke injury through the Nrf2
signaling pathway [73].
Cocoa polyphenols have shown the capacity to inhibit the expression activation of MAPKs
and NF-kB signaling in 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced mouse skin that
cause superoxide-anion generation [81] and in rats model of azoxymethane (AOM)-induced colon
carcinogenesis, respectively [82].
Both TNF-α protein and mRNA levels thereof measured in white adipose tissue and the
pro-inflammatory chemokine MCP-1 decreased when cocoa protein was administered in rats after
a high fat diet [83]. Besides that, the secretion and the mRNA levels of pro-inflammatory cytokines as
TNF-α and IL-6 were inhibited by theobromine treatment [28].
Pandurangan et al. (2015) explored the antioxidant properties of cocoa in a mouse model with
colitis-associated cancer induced by azoxymethane (AOM)/dextran sulfate sodium (DSS). This study
revealed that the administration of 5 and 10% cocoa in the diet caused a higher Nrf2 accumulation
in the nucleus of colon cells and reduced the COX-2 expression, an inflammatory mediator that is
increased during AOM/DSS-induction [84].
3.5. Olea Europaea
The possible anti-inflammatory action of the extract of O. europaea or isolated phenolic compounds
of this matrix has been evaluated by various authors in both in vitro and in vivo assays. In the case of
in vitro assays, peritoneal murine macrophage models stimulated with LPS, astrocytes induced by
lipopolysaccharide and different types of cells with induced inflammation have been used.
In this way, Cárdeno et al. (2014) evaluated the potential anti-inflammatory mechanisms of
the phenolic extract from EVOO on LPS-stimulated peritoneal murine macrophages. They obtained
that this extract decreased LPS-induced inflammatory responses through the reduction of AMPK
phosphorylation and the prevention of the NF-κB translocation [74].
Some of the compounds responsible for the anti-inflammatory capacity of the olive leaf and
fruit, such as maslinic acid [75], oleuropein [76,91], oleacein [76], hydroxytyrosol and tyrosol [92],
have been isolated and tested to verify their effects on the main metabolic pathways involved in
the inflammatory response. For example, maslinic acid, an oleanane-type triterpenoid, has shown
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an anti-inflammatory effect in astrocytes induced by LPS. The results demonstrated that maslinic acid
attenuated LPS-induced translocation of NF-κB p65 subunit to the nucleus and avoided LPS-induced
IκBα phosphorylation in a concentration-dependent manner [75].
Furthermore, hydroxytyrosol and tyrosol have shown an anti-inflammatory effect in several
studies. These compounds were capable of decreasing the NF-κB pathway and downregulating genes
and pathways related to inflammation, such as COX-2, IL-1β, TNF-α, Nrf2, HO-1, in different cell
lines with induced inflammation [92–94]. Another study revealed that both oleuropein and oleacein
caused a strongly increased expression of HO-1 and Nrf2 levels in CD31+/VEGFR-2+ cells decreased
by angiotensin II treatment [76]. In addition, the effect of oleuropein was tested in experimental
autoimmune myocarditis rats, resulting in a decrease in serum production of TNF-α, IL-1β and IL-6
and an attenuation of the MAPKs and NF-κB pathways [85].
Finally, other parts of the plant besides the fruit also have bioactive compounds that can exert beneficial
effects on health. Thus, olive leaf extract has been tested in rats with cyclophosphamide-induced renal
injury [86] and in rats with testicular damage induced by intraperitoneal injection [87]. In both models,
the inflammation caused by the injury was reduced by the effect of olive leaf extract. This anti-inflammatory
response was exerted due to the capacity of the compounds present in the olive leaf extract to inhibit the
translocation of NF-κB, suppress pro-inflammatory markers and increase the expression of Nrf2, HO-1
and NQO-1.
4. Effect of Bioactive Compounds on Aging
Aging is a complex process characterized by the accumulation of molecular, cellular and organ
damage. All these damages lead to loss of function and increase vulnerability to disease and death [95].
The hallmarks of aging can be organized into three key features. The primary hallmarks consist of
harm to cellular functions: telomere attrition, genomic instability, loss of proteostasis and epigenetic
alterations. Due to these damages, a series of antagonistic responses are produced: deregulated nutrient
detection, altered mitochondrial function and cellular senescence. Finally, integrative hallmarks give
rise to the characteristic clinical phenotype of the aging that ends in the physiological reserve loss,
the decrease of organs and the reduced function [96].
Several studies have shown that dietary or calorie restriction increase the lifespan of diverse
organisms, furthermore in monkey rhesus and humans this restriction protects against age-related
pathologies like cancer, diabetes, Alzheimer’s disease and cardiovascular disease [95].
The extension of lifespan mediated by the calorie restriction is mediated by mechanisms that end
in autophagy. Furthermore, calorie restriction downregulates the mTOR pathway and upregulates
SIRT1 deacetylase and the AMPK pathway, all of these pathways also upregulate autophagy [96].
Autophagy decreases with age, improving this degradation route of misfolded proteins, damaged
organelles and intracellular pathogens which will prevent their accumulation and, therefore, related
diseases. If attention is paid to the effect of metabolic regulation on aging, the downregulation of
mTOR pathway, one of the main nutrient sensors and metabolic regulation, either with rapamycin
or deletion of ribosomal S6 protein kinase 1 (S6K1) has shown an increase of mouse lifespan [95].
Another important protein in the detection of nutrients is AMPK, this kinase is activated with nutrient
starvation, caloric restriction, and exercise, since there is a decrease in ATP and an increase in AMP in
these processes. AMPK activation has been reported to promote cell survival under environmental
stress and this is related to autophagy [96]. In this sense, a high level of AMP has been also linked to
the accumulation of NAD that participates in caloric restriction. High levels of NAD activate sirtuins
in situations of nutrient deprivation or growth inhibitory signaling. There is evidence that sirtuins
participate in the regulation of insulin signaling and that they act as regulators of longevity [96].
Nevertheless, the role of sirtuins is still unclear.
On the other hand, the mitochondrial free radical theory of aging states that continued exposure
to reactive oxygen species causes mitochondrial DNA to increase susceptibility to oxidative damage
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and aging [97]. Consequently, any damage that affects mitochondrial DNA, dynamics, biogenesis or
integrity resulting in deregulated metabolism that is associated with aging.
Another highlight is the ability of different homeostasis maintenance mechanisms in mammals.
This responds to different nutrients and hormones to maintain physiological blood glucose levels [96].
With age, many of these sensors and molecular targets are lost or decreased, and this is related to
diseases associated with old age, such as cardiovascular and metabolic disorders, muscular atrophy,
neurodegenerative diseases and cancer susceptibility [96].
Table 3. In vivo studies of the included sources on the main metabolic pathways related to aging.
Model Type Source Effective Dose Parameters References
Aging mice S. marianum proteinhydrolysate
400, 800 and 1.200 mg/kg
daily for 7 weeks Liver mitochondria damage [98]
C. elegans Silymarin(S. marianum extract) 25 and 50 µM Lifespan [99]
Rabbits L. citriodora extract 2.2 g per 100 kg of feed Oxidative damage markers [100]
Rabbits Verbascoside (isolated fromL. citriodora) 5 mg/kg for 80 days
Sirt1 activity and
antioxidant levels [63]
Yeast BY4741 H. sabdariffa extract 100 µL of 300 ppm Lifespan [101]
Medaka fish Phenolic compounds-enrichedcocoa extract 1, 4 and 8 mg/mL for 4 days Lifespan and oxidative stress [102]
Aged rats O. europaea leaf extract 1000 mg/kg daily for2 months Antioxidant parameters [103]
C. elegans Oleuropein aglycone (isolatedfrom O. europaea) -
Aggregation of proteins in
amyloid diseases [104,105]
Type 2 diabetic patients Silymarin(S. marianum extract)
140 mg thrice daily for
45 days Antioxidant indices [106]
Elderly individuals T. cacao flavanol consumption 993, 520 and 48 mg daily for8 weeks Cardioprotective effect [107]
Besides, aging is also related to an increase in pro-inflammatory cytokines, which is known to interfere
with the insulin action. These cytokines result in both the secretion and production of pro-inflammatory
cytokines by increasing the number of senescent cells or by the greater accumulation of visceral fat
associated with age, respectively [108]. Certain of these cytokines and inflammatory markers are leptin,
TNF-α, IL-6 and plasminogen-1 activation inhibitor. All of them have been related to chronic conditions
associated with age [108]. In Table 3, it can be observed different in vivo studies that show the effect of the
matrices included in this review on the main metabolic pathways related to aging.
4.1. Silybum Marianum
The action of S. marianum on metabolic pathways related to aging and its effect on increasing lifespan
have been evaluated by different authors using in vivo studies. As an example, d-galactose-induced aging
mice were used to prove the antioxidant and anti-aging effects of S. marianum protein hydrolysate (SMPH).
The results showed that this compound exerted a beneficial effect against aging since it restored the damage
induced by d-galactose in liver mitochondria [98]. In this sense, silymarin and 2,3-dehydrosilybin A/B (DHS)
from S. marinanum have also been shown to promote lifespan in C. elegans [99].
On the other hand, it is known that several neurodegenerative diseases related to age occur when
there is an increase in oxidative stress, so it is a key aspect to be analyzed. Silymarin supplementation
improves antioxidant indices, like the activity of SOD, GPX activity and total antioxidant capacity
(TAC) whereas it reduces inflammatory markers in type 2 diabetic patients [106].
4.2. Lippia Citriodora
Palazzo et al. (2019) evaluated the effect of L. citriodora extract in rabbits, observing that there
were improvements in the functions of the liver and kidney in the markers of oxidative damage and
in the lipid profile of the animals by the action of the extract. Due to the relationship between the
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antioxidant effect and caloric restriction with the anti-aging effect, these effects exerted by the extract
may be related to protection against aging [100].
Other results that support the anti-aging effect of L. citriodora are those obtained by Corbi et al. (2018).
This study proved the effect of verbascoside in rabbits, demonstrating a relationship between the compound
administration and the SIRT1 activation in the rabbit’s heart and liver tissue. This suggested that SIRT1
could mediate the antioxidant effects of this extract [63]. In addition, the activation of SIRT1 is related to
an increase in autophagy, which in turn increases animal’s lifespan [96].
4.3. Hibiscus Sabdariffa
The anti-aging effect of H. sabdariffa was evaluated by Sarima et al. (2019) observing that the
H. sabdariffa petal extract extended the lifespan of yeast BY4741 under oxidative stress and normal
conditions. The extract was able to induce intracellular mechanisms against oxidative stress such as
modification of mitochondrial activity and upregulation of genes involved in tolerance mechanism
opposed to oxidative stress and key genes in aging pathway like SIR2 [101]. Moreover, the antigenotoxic
effect associated with the hibiscus extracts has been related to its antioxidant capacity and therefore to
the anti-aging effect [109,110].
4.4. Theobroma Cacao
The effect of compounds present in the T. cacao extract on aging has been evaluated in both in vitro
and in vivo assays. Phenolic compounds-enriched cocoa extract has also shown to participate in the
regulation of the expression of several genes involved in oxidative stress and prolonged lifespan in
medaka fish. The extract induced the activation of the antioxidant defense when an oxidative stress
situation is produced. Regarding the lifespan extension, in medaka fish, the activation of the SIRT1
protein did not occur directly but was done indirectly in a similar way to that produced in mammals.
The extract activated Epac1, a cAMP effector protein, which leads to high levels of CAMP and indirectly
activates the enzymatic function SIRT1 [102].
On the other side, one of the diseases with a high prevalence in old aging is cardiovascular disease.
Cocoa phenolics have shown cardioprotective effects in different studies that were carried out both in
cell and in human trials through the antioxidant, anti-inflammatory and antihypertensive properties of
these phenolic compounds from cocoa [107,111,112].
4.5. Olea Europaea
Olive phenolic compounds have been linked to an anti-aging effect due to several capacities to
produce protective effects. The administration of O. europaea leaf extract at a dose of 1000 mg/kg in
aged rats showed a decrease in high levels of hepatic malondialdehyde (MDA), diene conjugate (DC)
and carbonyl protein (PC) that appears in aged rats. This anti-aging effect presented by the extract
may be related to its strong radical scavenging action, acting as an antioxidant itself without affecting
the anti-oxidant system [103].
Moreover, protective effects from polyphenols of O. europaea have been proven in both C. elegans
and in humans. Examples of these effects are the interference with the aggregation of proteins in
amyloid diseases, the protection of cells and tissues against aging-associated functional disturbance
or the transcriptional modulation through epigenetic modifications [104,105]. Olive phenolics have
also been linked to anti-aging and cardioprotective properties because they present similar effects to
caloric restriction in tissues and organs such as muscle, brain, fatty tissue and kidneys in several ways,
but specifically through increased levels and activation of sirtuins [113,114].
5. Bioavailability and Pharmacokinetic Properties of Phenolic Compounds
The pharmacological potency of the phenolic compounds is important for the effect that they
exert in biological systems. However, their efficacy does not depend only on this potency but also
their bioavailability and pharmacokinetic parameters are important. For example, there are phenolic
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compounds that are rapidly absorbed by the intestinal barrier and plasma in their native state,
while others are absorbed in small quantities and may be highly metabolized or rapidly excreted [18].
Therefore, understand the bioavailability, absorption and metabolism of plant polyphenols is essential
to determine their mode of action and their final active metabolites.
Accordingly, the metabolites that reach the circulating blood and target tissues may differ from
their native forms and the gastrointestinal tract plays a crucial role in this. Phenolic compounds suffer
modifications throughout the gastrointestinal tract, first the compounds are hydrolyzed by gastric
fluid in the stomach and then metabolized by enzymes of the intestinal cells or catabolized by the
microflora of the colon, which can greatly affect the absorption of these compounds [18]. In addition,
phenolic compounds can undergo phase I and phase II reactions in the liver. The modifications that
the compounds suffer most frequently are glucuronidation, sulfation, and methylation. [11,115].
As mentioned earlier, the five matrices selected to be the subject of this review contain several
types of phenolic compounds. As mentioned, whole phenolic extracts or isolated phenolic compounds
are responsible for the attributed effect of these matrices on the metabolic pathways related to
energy metabolism, inflammation, and aging. However, as indicated in this point, it is important
to take into account the metabolites resulting from the ingestion of these matrices on the mentioned
metabolic pathways.
In L. citriodora verbascoside and isoverbascoside have an effect within the studied metabolic
pathways, so it is interesting to consider their bioavailability and pharmacokinetic properties. In this
way, the effect of the consumption of an oral acute dose of L. citriodora extract (1440 mg/kg) on the
antioxidant response of blood cells was further studied in rats using high-resolution mass spectrometry
in order to determine other potential metabolites in plasma [116]. In the study, these compounds
were found at high levels intact in plasma, suggesting that both compounds could be absorbed in
their native forms. However, five other metabolites derived from verbascoside and isoverbascoside
by deglycosylation (hydrolysis), methylation or glucuronidation were also found in plasma, namely
hydroxytyrosol, ferulic acid, caffeic acid, ferulic acid glucuronide, and homoprotocatechuic acid,
together with another eight phenolic compounds [116]. In other study, Wistar rats were orally treated
with a dosage of 2000 mg/kg of L. citriodora extract that contained a 25% of verbascoside. Blood samples
were taken at different times after ingestion and verbascoside was found in plasma samples with
a maximum concentration at 20 min. This study concluded that there was a fast absorption of
verbascoside in the gut barrier but a very low bioavailability, which may compromise to assign the
observed effects to verbascoside. However, there was evidence of the bioactivity of phenylpropanoids
at very low concentrations in cell models (at the micromolar range), so low micromolar concentrations
of verbascoside over a long-term in plasma could be responsible for some of the effects of the plant [117].
Concerning H. sabdariffa polyphenol-enriched extract, the bioavailability and pharmacokinetic
parameters were evaluated in Wistar rats after an acute oral dose of 1200 mg/kg [118]. In this study,
it was detected in plasma a total of 17 compounds, 11 of these were metabolites. Phenolic acids
appeared in plasma without any modification while most of flavonols were found as kaempferol or
quercetin glucuronide conjugates, reaching maximum concentration at 120 min. Of all the quercetin
and kaempferol derivatives in plasma, both quercetin glucuronide and aglycone had the highest
concentrations. These compounds showed higher removal values, revealing an accumulation of tissue
and a probable long-term effect [118].
Cocoa polyphenols include a subclass of flavonoids, namely flavan-3-ols, occurring as monomers,
mainly epicatechin and catechin, oligomers (procyanidins B1, B2, and C1) and polymers (up to ten units),
known as procyanidins [119]. The metabolism of flavan-3-ols has been frequently studied because
they have experienced being more bioavailable compared to other cocoa polyphenols. The metabolic
changes of frequent flavan-3-ols cocoa have been studied after consumption as well as the physiological
levels of epicatechin and catechin [115]. For example, Actis-Goretta et al. (2012) clarified that after
the consumption of dark chocolate, (−)-epicatechin-3’-β-d-glucuronide, (−)-epicatechin 3’-sulfate and
3’-O-methyl epicatechin sulfates substituted at positions 4′, 5 and 7 were the most relevant metabolites
Molecules 2020, 25, 596 18 of 27
of (−)-epicatechin found in plasma. In addition, the total urine excretion of (−)-epicatechin was 20% of
the amount ingested [120].
Taking into account hydroxytyrosol from O. europaea, the bioavailability of this simple phenol has
been explored in humans, for example in the trial conducted by Miro-Casas et al. where quantified
hydroxytyrosol and its main metabolite such as 3-O-methylhydroxytyrosol in plasma and urine after
a dose of 25 mL of virgin olive oil in healthy humans. The results showed that hydroxytyrosol
and 3-O-methyl-hydroxytyrosol in plasma increased as a response to virgin olive oil administration,
reaching maximum concentrations at 32 and 53 min and that approximately 98% of hydroxytyrosol was
present in conjugated forms, mainly glucurono-conjugates. With these results, the authors suggested
that ingested hydroxytyrosol can be extensively metabolized for the first time in the intestine and liver
and that the biological activity of this compound may be probably derived from its metabolites [121].
In another study, nine healthy volunteers were randomized to receive encapsulated or liquid olive leaf
extract as a single lower dose (51.1 mg of oleuropein, 9.7 mg of hydroxytyrosol) or higher (76.6 mg
of oleuropein, 14.5 mg of hydroxytyrosol). Then, the opposite dose (but the same formulation) one
week later was administered. In the study, fifteen phenolic olive compounds were rapidly found
in plasma and urine. They were mainly metabolites derived from phase II; three of them were
metabolites derived from hydroxytyrosol, four from oleuropein aglycone and two from homovanilic
acid, being hydroxytyrosol glucuronide found in greater quantity. In addition, new metabolites derived
from oleuropein in the urine were identified, such as elenolic acid, homovanilic alcohol sulfate and
glucuronide of elenolic acid. These results confirmed the rapid absorption of phenolic compounds
from the extract of O. europaea and the extensive biotransformation of hydroxytyrosol and oleuropein
into metabolites, mainly as glucuronidated conjugates, as mentioned above [122].
In the case of the S. marianum, no bioavailability and pharmacokinetic studies have been found to
comment on the main metabolic transformations of its main phenolic compounds.
Finally, in this section, some of the transformations suffered by the main phenolic compounds
of the matrices under study have been summarized. It can be seen that many of these appear in
plasma natively and, therefore, can exert the bioactive effect, but also that many of them undergo
modifications that make them transform into new compounds with different bioactive capacities
from their native form. These results suggest that the aforementioned effects of the natural sources
on metabolic pathways (Figure 1) may be due to native forms of the phenolic compounds or their
metabolic transformations.
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Figure 1. Molecular signaling pathways that are activated or inactivated by dietary phenolics or their
metabolites in oxidative stress, inflammation process, and aging. SM: Silybum marianum; LC: Lippia citriodora;
HS: Hibiscus sabdariffa; TC: Theobroma cacao; OE: Olea europaea; AMPK: AMP-activated protein kinase; mTOR:
the mammalian target of rapamycin; ATP: Adenosine triphosphate; AMP: Adenosine monophosphate;
ROS: Reactive oxygen species; LKB1: liver kinase B1; CaMKK β: Ca2+/calmodulin-dependent protein
kinase β; SIRT1: Sirtuin 1; ACC: Acetyl-CoA carboxylase; FAS: Fatty acid synthase; NF-kB: Nuclear
factor-κB; IKKβ: IkB kinase; COX-2: Cyclooxygenase-2; Akt: Protein kinase B; PI3K: Fosfoinositol
3-quinasa; Keap1: Kelch-like ECH-associated protein; Nrf2: Nuclear factor-erythroid 2 p45-related
factor 2; MEK 1/2: Mitogen-activated protein kinase 1/2; ERK 1/2: Extracellular signal-regulated kinase
1/2; GPCR: G protein-coupled receptor; IGF-R: Insulin-like growth factor receptor; IR: Insulin receptor;
ARE: Antioxidant response element; HO-1: Heme oxygenase 1; CO: Carbon monoxide; C/EBP-α:
CCAAT/enhancer-binding protein α; PPAR-γ: Proliferator Peroxisome Activated Receptor-γ; SREBP-1c:
Sterol regulatory element-binding protein-1c; IL-1: Interleukin-1; IL-6: Interleukin-6; TNF-α: Tumor
necrosis factor α. Thin green arrows indicate the activation of a molecule; thin red lines indicate the
inactivation of a molecule; thick green arrows indicate the promotion of a process; thick red lines indicate
the reduction of a process; thick orange lines indicate the translocation of molecules.
6. Conclusions
Beyond the potential of scavenging free radicals of dietary phenolic compounds, multiple cellular
and molecular pathways have been shown to be involved in their roles on different chronic disorders,
showing their pleiotropic nature.
As can be seen throughout this review, the metabolic pathways related to energy metabolism,
inflammation, and aging are closely related and share central molecules in their regulation. Despite this
intimate relationship, there are key molecules in any one of them, which are subject to the regulatory
effect of phenolic compounds.
Focusing attention on the metabolic pathways involved in energy metabolism, it can be seen
that AMPK exerts an effect as a central regulator, since its activation or inhibition can trigger an effect
on other important molecules of energy metabolism. In addition, the activation of AMPK leads to
the inhibition of ATP-consuming anabolic pathways, which translates into the inhibition of molecule
synthesis processes and the activation of reserve cell degradation. Another important molecule in
energy metabolism is mTOR, whose negative regulation is directly related to the activation of AMPK.
Several studies, both in vitro and in vivo have shown that entire extracts from natural sources have
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a positive regulatory effect on AMPK and negative on mTOR, highlighting L. citriodora extract or its
main compound verbascoside isolated, S. marianum extract and secoiridoids from extra virgin olive oil.
In the case of the inflammation-related metabolic pathways, there are two main molecules on
which the phenolic compounds have been shown to have a regulatory effect, Nrf2, and NF-κB. Nrf2
plays an important effect in several inflammatory diseases because the absence of Nrf2 in the nucleus
has reflected greater symptoms of inflammation while the presence of NF-κB in the nucleus triggers
an inflammatory response since it causes the transcription of pro-inflammatory mediators. Both Nrf2
and NF-κB have been shown to be the target of the pleiotropic effect of phenolic compounds in both
in vitro and in vivo studies. Some examples noted are the effect of silybin and isosilybin, isolated from
S. marianum extract, whole L. citriodora extract and (−)-epicatechin, isolated from T. cocoa.
As for the aging-related metabolic pathways, there are many common intermediaries to the two
mentioned above, so many of the aforementioned effects of phenolic compounds on energy metabolism and
inflammation would also have an effect on the regulation of aging. Note the central regulator of metabolism,
AMPK, and sirtuins. The effect of sirtuins on the regulation of longevity has been studied by various authors
although their role on aging today is not entirely clear. Because the metabolic pathways related to aging
share many molecules with the other two mentioned, the vast majority of the aforementioned effects of the
revised phenolic compounds on energy metabolism and inflammation could also be considered a regulatory
effect of aging. Therefore, it should be taken into account that verbascoside (isolated from L. citriodora) has
shown an effect on certain sirtuins, which makes it potentially effective in aging.
From the data summarized in this review, it is very clear that different pathways are involved to
trigger their potential even in different pathologies. However, further studies are still needed to assess the
therapeutic and pharmacological potentials of these bioactive compounds due, as mentioned in Section 5,
to the pharmacological potency of the phenolic compounds also depend on their bioavailability. For this
reason, it is necessary to elucidate if the effects of the studied compounds are effective in their native form or
if the metabolic transformations thereof are those that actually exert the bioactive effect.
With this review, it is possible to obtain an integrative image of the existing relationships of
the metabolic pathways related to energy metabolism, inflammation, and aging. It also highlights
the pleiotropic effect of different types of phenolic compounds on key molecules of these metabolic
pathways and their relationship with certain chronic diseases.
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